SCHEMBL7090549

SCHEMBL7090549

CCN(Cc1cccc(C(=N)N)c1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 5/20 0.57
GRIN3B O60391 5/20 0.57
GRIN1 Q05586 5/20 0.57
GRIN2A Q12879 5/20 0.57
GRIN2B Q13224 5/20 0.57
GRIN2C Q14957 5/20 0.57
GRIN3A Q8TCU5 5/20 0.57
PPARG P37231 1/20 0.54
PRSS1 P07477 2/20 0.53
PRSS2 P07478 2/20 0.53
PRSS3 P35030 2/20 0.53
LOXL2 Q9Y4K0 1/20 0.51
LMNA P02545 1/20 0.50
F10 P00742 5/20 0.47
KMT2A Q03164 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ALDH1A1 P00352 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089328 0.90 PRSS1 (0.61) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7083226 0.89 GRIN2D (0.59) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7083982 0.87 GRIN2D (0.61) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7090135 0.85 GRIN2D (0.56) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7084315 0.85 GRIN2D (0.60) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7089289 0.85 PRSS1 (0.49) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7087241 0.83 F10 (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7083688 0.83 PPARG (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7083845 0.82 MEN1 (0.56) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL14662383 0.81 PRSS1 (0.57) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030199698-A1 Carbamic acid esters as inhibitors of factor xa MERCK PATENT GMBH (DE) 2003-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199698-A1 Carbamic acid esters as inhibitors of factor xa F11, F12, F13A1 GRIN2D 3815/4885GRIN3B 3753/4885GRIN1 1030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.